Abstract
Summary: There is considerable evidence that homocystine has a direct damaging effect on vascular endothelium and other tissues. The demonstration of the existance of protein-bound homocyst(e)ine has strengthened this hypothesis. In an attempt to remove bound homocyst(e)ine, D-penicillamine was given to three patients with pyridoxine-nonresponsive homocystinuria. Before the clinical trial, it had been demonstrated that 0.1 μmole per ml concentration of D-penicillamine or cysteamine released approximately 50% of the homocyst(e)ine bound to plasma proteins in vitro. Oral D-penicillamine effectively reduced both free and plasma protein-bound homocyst(e)ine in homocystinurics from the second day of treatment. The homocystine excreted in the urine was mainly in the form of homocysteine-penicillamine disulfide. No mixed disulfide was detectable in the plasma, indicating an extremely high renal clearance. These observations suggested that oral D-penicillamine removed a considerable quantity of the bound homocyst(e)ine accumulated in the tissue proteins.
Speculation: D-Penicillamine treatment may be used on an experimental basis in pyridoxine-nonresponsive homocystinuric patients when dietary treatment is not practical. It may also be used in pyridoxine-responsive patients when control with pyridoxine is unsatisfactory. In addition, determination of protein-bound homocyst(e)ine should be used for the assessment of the effectiveness of therapy.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kang, SS., Wong, P. & Curley, K. The Effect of D-Penicillamine on Protein-Bound Homocyst(e)ine in Homocystinurics. Pediatr Res 16, 370–372 (1982). https://doi.org/10.1203/00006450-198205000-00010
Issue Date:
DOI: https://doi.org/10.1203/00006450-198205000-00010
This article is cited by
-
Total plasma homocysteine: influence of some common physiological variables
Amino Acids (1993)